Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,098.37
+13.390.64%
Number of Gainers:694
Number of Losers:312
Number of Flat:16
PE:- -
High:2,100.17
Open:2,085.26
Low:2,085.25
Close:2,084.98
Volume:4.90B
Turnover:580.93B
Market Cap:97.61T
Float Cap:91.37T

Loading ...

3 Semiconductor Stocks to Buy Ahead of Earnings, According to Analysts

TIPRANKS
·
Oct 02

These Analysts Cut Their Forecasts On Nike Following Q1 Results

Benzinga Earnings
·
Oct 02

Tesla Posts Stronger-than-Expected Quarterly Deliveries

Reuters
·
Oct 02

Blackstone Initiated at Equal-Weight by Wells Fargo

Dow Jones
·
Oct 02

Nvidia - Dgx Spark 64Gb Available Oct 23 from $4,999 Via Major Partners

THOMSON REUTERS
·
Oct 02

Nvidia - Dgx Spark 64Gb Supports up to 100-Billion-Parameter Models on Device

THOMSON REUTERS
·
Oct 02

A.O. Smith Schedules Third-Quarter Earnings Conference Call

Reuters
·
Oct 02

iTonic Holdings Announces 16-for-1 Share Consolidation Effective Oct. 6

Reuters
·
Oct 02

Norfolk Southern Schedules Third-Quarter Earnings Conference Call

Reuters
·
Oct 02

Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients

Reuters
·
Oct 02

ATA Creativity Global Gets NASDAQ Notice After ADS Bid Price Stays Below $1

Reuters
·
Oct 02

ProKidney Posts Pooled Phase 2 Data Showing Rilparencel Stabilizes Kidney Function in Advanced CKD with Diabetes

Reuters
·
Oct 02

Cuprina to Buy Singapore Healthcare Group East Coast Podiatry and Orchard Clinic for S$4 Million

Reuters
·
Oct 02

Evaxion to Present New Phase 2 Immune Data for EVX-01 Melanoma Vaccine at SITC 2026

Reuters
·
Oct 02

Candel Therapeutics to Present NSCLC Aglatimagene Besadenovec Study Data at SITC 2026

Reuters
·
Oct 02

Notable open interest changes for October 2nd

TIPRANKS
·
Oct 02

Tesla Inc: Q3 Total Production 464,391 Units, Visible Alpha Estimate 486,761 Units

THOMSON REUTERS
·
Oct 02

Tesla Inc: in Qtr, Deployed 13.7 Gwh of Energy Storage Products

THOMSON REUTERS
·
Oct 02

Argus Research Adjusts Becton, Dickinson and Company Price Target to $210 From $180, Maintains Buy Rating

MT Newswires Live
·
Oct 02

MiNK Therapeutics Highlights Phase 2 Trial Testing agenT-797 with Botensilimab and Balstilimab in MSS Colorectal Cancer Liver Metastases

Reuters
·
Oct 02